Effect of Age on the Conformity Rate to Short-Acting Beta-Agonist Use Criteria in Asthma

Journal of Asthma

Volumn 40, Issue 7, 2003, Pages 829-835

  Labrecque, M ^a   Laurier, C ^b   Champagne, F ^b   Kennedy, W ^b   Pare M ^b   Cartier, A ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Asthma drug therapy; Asthma management; Consensus guidelines

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASTHMA; CANADA; CHILD; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

EID: 0242664783     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120024168     Document Type: Article

References (19)

1. Fitzgerald ST. National Asthma Education Program Expert Panel report: guidelines for the diagnosis and management of asthma. AAOHN J 1992; 40:376-382.
2. Ernst P, Fitzgerald JM, Spier, S. Canadian asthma consensus conference summary of recommendations. Can Respir J 1996; 3(2): 89-100.
3. Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. Can Med Assoc J 1999; 161 (suppl 11):S1-S62.
4. Legorreta AP, Christian-Herman J, O'Connor RD, Hasan MM, Evans R, Leung KM. Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience. Arch Intern Med 1998; 158(5):457-464.
5. Nestor A, Calhoun AC, Dickson M, Kalik CA. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population. Ann Allergy Asthma Immunol 1998; 81(4):327-330.
6. Laumann JM, Bjornson DC. Treatment of medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology. Ann Pharmacother 1998; 32(12):1290-1294.
7. Blais R, Gregoire JP, Rouleau R, Cartier A, Bouchard J, Boulet LP, Ambulatory use of inhaled beta(2)-agonists for the treatment of asthma in Quebec: a population-based utilization review. Chest 2001; 119(5):1316-1321.
8. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332(13):868-875.
9. Kelly HW. Comparison of inhaled corticosteroids. Ann Pharmacother 1998; 32(2):220-232.
10. Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Ohlsson SV. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European respiratory society study on chronic obstructive pulmonary disease [see comments]. N Engl J Med 1999; 340(25):1948-1953.
11. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153(5):1481-1488.
12. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344(8917):219-224.
13. Jatulis DE, Meng YY, Elashoff RM, Schocket AL, Evans RM, Hasan AG, Legorreta AP. Preventive pharmacologic therapy among asthmatics: five years after publication of guidelines. Ann Allergy Asthma Immunol 1998; 81(1):82-88.
14. Habbick B, Baker MJ, McNutt M, Cockcroft DW. Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. Can Med Assoc J 1995; 153(10):1437-1443.
15. Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995; 8(6):899-904.
16. Partridge MR. Delivering optimal care to the person with asthma: what are the key components and what do we mean by patient education? Eur Respir J 1995; 8:298-305.
17. Bindman AB, Grumbach K, Osmond D, Komaromy M, Vranizan K, Lurie N, Billings J, Stewart A. Preventable hospitalizations and access to health care. JAMA 1995; 274(4): 305-311.
18. Claudio L, Tulton L, Doucette J, Landrigan PJ. Socioeconomic factors and asthma hospitalization rates in New York City. J Asthma 1999; 36(4):343-350.
19. Gottlieb DJ, Beiser, AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest 1995; 108(1):28-35.